Why IMU is a multi multi bagger, page-19851

Good morning, friend wasa!

It is always a good morning for me when I see a post from @Wasabibarako , because you are such an unfailingly kind, thoughtful and generous presence on these forums. If the "IMU at a $" party (or even the IMU at $2 party) ever happens, then I hope you can make it to these shores to attend. If so - I will definitely be there myself to share a drink of your choice. If you can't get there - name a destination and my wife and I might just take another holiday...

I agree with you about 2024. I think a year ago I said something about 2023 being a very big year for Imugene, and I believe it has been exactly that. The huge news, for me, was the initial data from the Vaxinia trial, which validated everything Professor Fong said when he visited in April and some of us (myself included) had the great pleasure of meeting him in person. However the Azer-cel acquisition almost matches that, as does the FDA Fast Track designation for Vaxinia. And then in the background we have the ongoing progress of OnCARlytics - with first patient dosed - and the announcement of the Neo-POLEM trial for PD1-vaxx. Plus some key 3rd party partnerships and some excellent new arrivals to the IMU team. And more.....

2024 looks like being the harvest year, to me. Or rather - the start of the harvest. There is so much to look forward to.

Very best wishes

Dave
,